Viologen-phosphorus dendrimers exhibit minor toxicity against a murine neuroblastoma cell line

Cellular and Molecular Biology Letters

Volumn 18, Issue 3, 2013, Pages 459-478

  Lazniewska, Joanna ^a   Milowska, Katarzyna ^a   Katir, Nadia ^b   El Kadib, Abdelkim ^c   Bryszewska, Maria ^a   Majoral, Jean Pierre ^b   Gabryelak, Teresa ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

^c MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Apoptosis; Cytotoxicity; N2a cell line; ROS; Viologen phosphorus dendrimers

Indexed keywords

DENDRIMER; PHOSPHORUS; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VIOLOGEN; VIOLOGEN PHOSPHORUS DENDRIMER;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOUSE; NANOTOXICOLOGY; NEUROBLASTOMA CELL; NONHUMAN;

HUMAN IMMUNODEFICIENCY VIRUS; MURINAE;

EID: 84884766377     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-013-0100-5     Document Type: Article

References (55)

1. Klajnert, B. and Bryszewska, M. Dendrimers: properties and applications. Acta Biochim. Pol. 48 (2001) 199-208.
2. Svenson, S. and Tomalia, D. A. Dendrimers in biomedical applicationsreflections on the field. Adv. Drug Deliv. Rev. 57 (2005) 2106-2129.
3. Menjoge, A. R., Kannan, R. M. and Tomalia, D. A. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug. Discov. Today15 (2010) 171-185.
4. Wang, B., Navath, R. S., Menjoge, A. R., Balakrishnan, B., Bellair, R., Dai, H., Romero, R., Kannan, S. and Kannan, R. M. Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers. Int. J. Pharm. 395 (2010) 298-308.
5. Luganini, A., Nicoletto, S. F., Pizzuto, L., Pirri, G., Giuliani, A., Landolfo, S. and Gribaudo, G. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers. Antimicrob. Agents Chemother. 55 (2011) 3231-3239.
6. Janiszewska, J., Sowińska, M., Rajnisz, A., Solecka, J., Łacka, I., Milewski, S. and Urbańczyk-Lipkowska, Z. Novel dendrimeric lipopeptides with antifungal activity. Bioorgan. Med. Chem. Lett. 22 (2012) 1388-1393.
7. Ottaviani, M. F., Mazzeo, R., Cangiotti, M., Fiorani, L., Majoral, J.-P., Caminade, A.-M., Pedziwiatr, E., Bryszewska, M. and Klajnert, B. Time evolution of the aggregation process of peptides involved in neurodegenerative diseases and preventing aggregation effect of phosphorus dendrimers studied by EPR. Biomacromolecules11 (2010) 3014-3021.
8. Milowska, K., Gabryelak, T., Bryszewska, M., Caminade, A.-M. and Majoral, J.-P. Phosphorus-containing dendrimers against α-synuclein fibril formation. Int. J. Biol. Macromol. 50 (2012) 1138-1143.
9. Wasiak, T., Ionov, M., Nieznanski, K., Nieznanska, H., Klementieva, O., Granell, M., Cladera, J., Majoral, J.-P., Caminade, A.-M. and Klajnert, B. Phosphorus dendrimers affect Alzheimer's (Aβ1-28) peptide and MAP-Tau protein aggregation. Mol. Pharm. 9 (2012) 458-469.
10. Albertazzi, L., Gherardini, L., Brondi, M., Sulis Sato, S., Bifone, A., Pizzorusso, T., Ratto, G. M. and Bardi, G. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. Mol. Pharm. 10 (2013) 249-260.
11. Dai, H., Navath, R. S., Balakrishnan, B., Guru, B. R., Mishra, M. K., Romero, R., Kannan, R. M. and Kannan, S. Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. Nanomedicine5 (2010) 317-1329.
12. Kannan, S., Dai, H., Navath, R. S., Balakrishnan, B., Jyoti, A., Janisse, J., Romero, R. and Kannan, R. M. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci. Transl. Med. 4 (2012) 130ra46.
13. Iezzi, R., Guru, B. R., Glybina, I. V., Mishra, M. K., Kennedy, A. and Kannan, R. M. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials33 (2012) 979-988.
14. Launay, N., Caminade, A. and Lahana, R. A general synthetic strategy for neutral phosphorus-containing dendrimers. Angew. Chem. Int. Ed. Engl. 33 (1994) 1589-1592.
15. Galliot, C. Regioselective stepwise growth of dendrimer units in the internal voids of a main dendrimer. Science277 (1997) 1981-1984.
16. Merino, S., Brauge, L., Caminade, A. M., Majoral, J. P., Taton, D. and Gnanou, Y. Synthesis and characterization of linear, hyperbranched, and dendrimer-like polymers constituted of the same repeating unit. Chemistry7 (2001) 3095-3105.
17. Caminade, A.-M., Turrin, C.-O. and Majoral, J.-P. Biological properties of phosphorus dendrimers. New J. Chem. 34 (2010) 1512-1524.
18. Babbs, C. F., Pham, J. A. and Coolbaugh, R. C. Lethal hydroxyl radical production in paraquat-treated plants. Plant Physiol. 90 (1989) 1267-1270.
19. Huang, C., Zhang, X., Jiang, Y., Li, G., Wang, H., Tang, X. and Wang, Q. Paraquat-induced convulsion and death: a report of five cases. Toxicol. Ind. Health (2012) DOI: 10. 1177/0748233712442712.
20. Spivey, A. Rotenone and paraquat linked to Parkinson's disease: human exposure study supports years of animal studies. Environ. Health Perspect. 119 (2011) A259.
21. Freire, C. and Koifman, S. Pesticide exposure and Parkinson's disease: Epidemiological evidence of association. Neurotoxicology33 (2012) 947-971.
22. Gollamudi, S., Johri, A., Calingasan, N. Y., Yang, L., Elemento, O. and Beal, M. F. Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease. PLoS ONE7 (2012) e36191.
23. Fukushima, T., Tanaka, K., Lim, H. and Moriyama, M. Mechanism of cytotoxicity of paraquat. Environ. Health Prev. Med. 7 (2002) 89-94.
24. Bielefeld, E. C., Hu, B. H., Harris, K. C. and Henderson, D. Damage and threshold shift resulting from cochlear exposure to paraquat-generated superoxide. Hear Res. 207 (2005) 35-42.
25. Asaftei, S. and De Clercq, E. "Viologen" dendrimers as antiviral agents: the effect of charge number and distance. J. Med. Chem. 53 (2010) 3480-3488.
26. Ciepluch, K., Katir, N., Kadib, El, A., Felczak, A., Zawadzka, K., Weber, M., Klajnert, B., Lisowska, K., Caminade, A.-M., Bousmina, M., Bryszewska, M. and Majoral, J. P. Biological properties of new viologen-phosphorus dendrimers. Mol. Pharm. 9 (2012) 448-457.
27. Ciepluch, K., Weber, M., Katir, N., Caminade, A.-M., Kadib, El, A., Klajnert, B., Majoral, J.-P. and Bryszewska, M. Effect of viologenphosphorus dendrimers on acetylcholinesterase and butyrylcholinesterase activities. Int. J. Biol. Macromol. 54 (2013) 119-124.
28. Milowska, K., Grochowina, J., Katir, N., Kadib, El, A., Majoral, J.-P., Bryszewska, M. and Gabryelak, T. Viologen-phosphorus dendrimers inhibit α-synuclein fibrillation. Mol. Pharm. 10 (2013) 1131-1137.
29. Milowska, K., Grochowina, J., Katir, N., Kadib, El, A., Majoral, J.-P., Bryszewska, M. and Gabryelak, T. Interaction between viologen-phosphorus dendrimers and α-synuclein. J. Lumin. 134 (2013) 132-137.
30. Baker, J. R. Dendrimer-based nanoparticles for cancer therapy. Hematology Am. Soc. Hematol. Educ. Program (2009) 708-719.
31. Guo, R. and Shi, X. Dendrimers in cancer therapeutics and diagnosis. Curr. Drug Metab. 13 (2012) 1097-1109.
32. Bernas, T. and Dobrucki, J. Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry47 (2002) 236-242.
33. Janaszewska, A., Ciolkowski, M., Wróbel, D., Petersen, J. F., Ficker, M., Christensen, J. B., Bryszewska, M. and Klajnert, B. Modified PAMAM dendrimer with 4-carbomethoxypyrrolidone surface groups reveals negligible toxicity against three rodent cell-lines. Nanomedicine (2013) DOI: 10. 1016/j. nano. 2013. 01. 010.
34. Bartosz, G. Use of spectroscopic probes for detection of reactive oxygen species. Clin. Chim. Acta368 (2006) 53-76.
35. Agnello, M., Morici, G., and Rinaldi, A. M. A method for measuring mitochondrial mass and activity. Cytotechnology56 (2008) 145-149.
36. Salvioli, S., Ardizzoni, A., Franceschi, C. and Cossarizza, A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 411 (1997) 77-82.
37. Ribble, D., Goldstein, N. B., Norris, D. A. and Shellman, Y. G. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 5 (2005) DOI: 10. 1186/1472-6750-5-12.
38. Michałowicz, J. and Sicińska, P. Chlorophenols and chlorocatechols induce apoptosis in human lymphocytes (in vitro). Toxicol. Lett. 191 (2009) 246-252.
39. Patel, D., Henry, J. and Good, T. Attenuation of β-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers. Biochim. Biophys. Acta1760 (2006) 1802-1809.
40. Kuo, J.-H. S., Jan, M.-S. and Lin, Y.-L. Interactions between U-937 human macrophages and poly(propyleneimine) dendrimers. J. Control Release120 (2007) 51-59.
41. Naha, P. C., Davoren, M., Lyng, F. M. and Byrne, H. J. Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A. 1 cells. Toxicol. Appl. Pharmacol. 246 (2010) 91-99.
42. Wang, W., Xiong, W., Wan, J., Sun, X., Xu, H. and Yang, X. The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress. Nanotechnology20 (2009) 105103.
43. Mukherjee, S. P., Lyng, F. M., Garcia, A., Davoren, M. and Byrne, H. J. Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol. Appl. Pharmacol. 248 (2010) 259-268.
44. Mukherjee, S. P. and Byrne, H. J. Polyamidoamine dendrimer nanoparticle cytotoxicity, oxidative stress, caspase activation and inflammatory response: experimental observation and numerical simulation. Nanomedicine9 (2012) 202-211.
45. Lee, J.-H., Cha, K. E., Kim, M. S., Hong, H. W., Chung, D. J., Ryu, G. and Myung, H. Nanosized polyamidoamine (PAMAM) dendrimer-induced apoptosis mediated by mitochondrial dysfunction. Toxicol. Lett. 190 (2009) 202-207.
46. Hong, S., Leroueil, P. R., Janus, E. K., Peters, J. L., Kober, M.-M., Islam, M. T., Orr, B. G., Baker, J. R. and Banaszak Holl, M. M. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membranepermeability. Bioconjugate Chem. 17 (2006) 728-734.
47. Leroueil, P. R., Hong, S., Mecke, A., Baker, J. R., Orr, B. G. and Banaszak Holl, M. M. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc. Chem. Res. 40 (2007) 335-342.
48. Leroueil, P. R., Berry, S. A., Duthie, K., Han, G., Rotello, V. M., McNerny, D. Q., Baker, J. R., Orr, B. G. and Holl, M. M. B. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano. Lett. 8 (2008) 420-424.
49. Ionov, M., Wrobel, D., Gardikis, K., Hatziantoniou, S., Demetzos, C., Majoral, J-P., Klajnert, B. and Bryszewska, M. Effect of phosphorus dendrimers on DMPC lipid membranes. Chem. Phys. Lipids165 (2012) 408-413.
50. Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W. and Ghandehari, H. Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm. Res. 24 (2007) 2138-2145.
51. Kitchens, K. M., Kolhatkar, R. B., Swaan, P. W. and Ghandehari, H. Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. Mol. Pharm. 5 (2008) 364-369.
52. Albertazzi, L., Serresi, M., Albanese, A. and Beltram, F. Dendrimer internalization and intracellular trafficking in living cells. Mol. Pharm. 7 (2010) 680-688.
53. Albertazzi, L., Fernandez-Villamarin, M., Riguera, R. and Fernandez-Megia, E. Peripheral functionalization of dendrimers regulates internalization and intracellular trafficking in living cells. Bioconjugate Chem. 23 (2012) 1059-1068.
54. Perumal, O. P., Inapagolla, R., Kannan, S. and Kannan, R. M. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials29 (2008) 3469-3476.
55. Healy, E., Dempsey, M., Lally, C. and Ryan, M. P. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int. 54 (1998) 1955-1966.